Bionter logo — Revolutionizing analytical testing to benefit people's healt...

Bionter

Revolutionizing analytical testing to benefit people's health

Founded 2020 Switzerland Basel, Switzerland 5 employees Seed Total: $3.00M Health Care, Pharmaceutical

General Information

Company Name Bionter
Founded Year 2020
Location Switzerland Basel, Switzerland +1
Employees 5
Industries Health Care, Pharmaceutical
Funding Stage Seed
Social

Get notified when Bionter moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Bionter

Bionter is a Swiss-based startup founded in 2020, with a vision to revolutionize analytical testing in the healthcare and pharmaceutical industries. The company's slogan, "Revolutionizing analytical testing to benefit people's health," reflects its commitment to making a positive impact on people's well-being. Bionter's focus on particle testing is of great significance as it addresses crucial aspects of patient safety and is integral to various stages of pharmaceutical development and manufacturing processes. The startup recently secured a noteworthy $3.00M in a Seed Round investment on 27 April 2022, with the investment coming from Dynamk Capital. This funding is a significant milestone for Bionter, signifying investor confidence in the company's potential to innovate and disrupt the analytical testing landscape. This financial backing will likely propel Bionter's efforts to further develop its product family and expand its market reach. In summary, Bionter's strategic focus on addressing critical needs in healthcare and pharmaceutical industries, combined with its recent successful funding round, positions the company as a promising player in the analytical testing sector. With its innovative approach and support from investors such as Dynamk Capital, Bionter is poised to make a meaningful difference in the health and well-being of individuals.

Taxonomy: analytical testing, particle testing, patient safety, pharmaceutical industry, stability testing, drug formulation, process development, health innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
27 Apr 2022

Bionter Alternatives & Competitors

Bionter vs

Shinyei Corporation of America is a subsidiary company of SHINYEI KAISHA founded in 1887.

5 employees
Design, Manufacturing
Bionter vs

TQCC offers NDT training, certification and consultancy services to companies and persons worldwide...

Grant
11 employees
Industrial
Bionter vs

Our aim is to provide efficient testing by qualified and experienced personnel, followed up with pro...

24 employees

FAQ About Bionter

Revolutionizing analytical testing to benefit people's health
Bionter was founded in 2020.
Bionter is headquartered in Basel, Switzerland.
Bionter operates in the following industries: Health Care, Pharmaceutical.
Bionter has approximately 5 employees.
Bionter has completed 1 funding round, raising a total of $3.00M. The latest funding stage is Seed.
Top alternatives and competitors to Bionter include Shinyei Corporation of America, TQCC NDT Training & Certification, Marine Inspection Service, Magnaflux, CritiTech Particle Engineering Solutions. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bionter and Shinyei Corporation of America are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Bionter and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy